105 related articles for article (PubMed ID: 31182685)
1. Correlation of 4-1BBL+ B Cells in Tumor Draining Lymph Nodes with Pathological Characteristics of Breast Cancer.
Arabpour M; Ghods A; Shariat M; Talei AR; Mehdipour F; Ghaderi A
Iran J Immunol; 2019 Jun; 16(2):108-116. PubMed ID: 31182685
[TBL] [Abstract][Full Text] [Related]
2. TNFR2 but not TNFR1 is the main TNFR expressed by B and T lymphocytes in breast cancer draining lymph nodes.
Ghods A; Ghaderi A; Shariat M; Talei AR; Mehdipour F
Immunol Lett; 2019 May; 209():36-44. PubMed ID: 30910714
[TBL] [Abstract][Full Text] [Related]
3. The balance of regulatory and stimulatory B cell subsets in breast cancer draining lymph nodes correlates with tumor prognostic factors.
Shariati S; Mehdipour F; Samadi M; Rasolmali R; Talei AR; Ghaderi A
Life Sci; 2020 Sep; 257():118117. PubMed ID: 32693243
[TBL] [Abstract][Full Text] [Related]
4. Granzyme B production by activated B cells derived from breast cancer-draining lymph nodes.
Arabpour M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A
Mol Immunol; 2019 Oct; 114():172-178. PubMed ID: 31357083
[TBL] [Abstract][Full Text] [Related]
5. CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer.
Vahidi Y; Bagheri M; Ghaderi A; Faghih Z
BMC Cancer; 2020 Mar; 20(1):257. PubMed ID: 32228503
[TBL] [Abstract][Full Text] [Related]
6. The significance of cytokine-producing B cells in breast tumor-draining lymph nodes.
Mehdipour F; Razmkhah M; Faghih Z; Bagheri M; Talei AR; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):381-395. PubMed ID: 30850950
[TBL] [Abstract][Full Text] [Related]
7. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.
Futagawa T; Akiba H; Kodama T; Takeda K; Hosoda Y; Yagita H; Okumura K
Int Immunol; 2002 Mar; 14(3):275-86. PubMed ID: 11867564
[TBL] [Abstract][Full Text] [Related]
9. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T Lymphocyte Subsets in Bladder Tumor Draining Lymph Nodes.
Faghih Z; Shobeiri SS; Ariafar A; Sarkarian M; Zeighami S; Nazari N; Abbasi-Sarvak S; Erfani N
Iran J Immunol; 2016 Dec; 13(4):237-248. PubMed ID: 27999236
[TBL] [Abstract][Full Text] [Related]
11. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
Yi KH; Nechushtan H; Bowers WJ; Walker GR; Zhang Y; Pham DG; Podack ER; Federoff HJ; Tolba KA; Rosenblatt JD
Cancer Res; 2007 Oct; 67(20):10027-37. PubMed ID: 17942937
[TBL] [Abstract][Full Text] [Related]
12. HBcAg-induced upregulated 4-1BB ligand on B cells contributes to B-cell hyperactivation during chronic hepatitis B infection.
Liu Y; Wang G; Chen Y; Huang R; Tian C; Li Y; Zhao XA; Wu C
J Med Virol; 2019 May; 91(5):781-790. PubMed ID: 30552705
[TBL] [Abstract][Full Text] [Related]
13. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
14. 4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes.
Sluijter BJ; van den Hout MF; Stam AG; Lougheed SM; Suhoski MM; van den Eertwegh AJ; van den Tol MP; van Leeuwen PA; Meijer S; Scheper RJ; June CH; de Gruijl TD; Santegoets SJ
Clin Immunol; 2010 Nov; 137(2):221-33. PubMed ID: 20708974
[TBL] [Abstract][Full Text] [Related]
15. 4-1BB ligand signaling to T cells limits T cell activation.
Eun SY; Lee SW; Xu Y; Croft M
J Immunol; 2015 Jan; 194(1):134-41. PubMed ID: 25404362
[TBL] [Abstract][Full Text] [Related]
16. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressive effects of WEE1 gene silencing could not enhance immunopotentiation effects of CD80 and 4-1BBL co-stimulation in human T cells.
Ghiasi N; Habibagahi M; Rosli R; Ghaderi A; Yusoff K; Hosseini A; Abdullah S; Jaberipour M
J Cancer Res Ther; 2015; 11(4):708-16. PubMed ID: 26881506
[TBL] [Abstract][Full Text] [Related]
18. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
19. CD8
E J; Yan F; Kang Z; Zhu L; Xing J; Yu E
Hum Immunol; 2018 Jun; 79(6):446-452. PubMed ID: 29544815
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo.
Dawicki W; Watts TH
Eur J Immunol; 2004 Mar; 34(3):743-751. PubMed ID: 14991604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]